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SUMMARY 
The concentrations of serum homovanillic acid (HVA), luteinizing liormone (LH), follicle-stimulating hormone 
(FSH) and testosterone (T) were examined in 20 male schizophrenic patients not taking neuroleptic drugs, 44 treated 
with neuroleptic drugs, and 15 male healthy control subjects. Kurskal-Wallis analysis of variance showed no 
significant difference among the three groups in serum HVA, FSH, LH or testosterone although high concentrations 
were found in tlte patients not taking neuroleptic drugs. There was a significant positive correlation between serum 
HVA and FSH in the patients not taking neuroleptics. The present results suggest that the change of gonadal 
hormones may be related to the pathogenesis of schizophrenia. 
INTRODUCTION 
Schizophrenia usually starts in adolescence (Hem-
mings, 1986) and the clinical manifestations differ some-
what between male and female patients (Goldstein & Link, 
1988), so that an abnormal activity of the gonadal system 
may be involved in the pathogenesis of schizophrenia. The 
concentrations of testosterone (T), luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) in the cir-
culation have been reported in schizophrenic patients as 
compared with healthy control subjects, but the con-
clusions seem to be inconsistent. Several authors have 
reported that there are low levels of serum testosterone, 
LH and FSH in schizophrenic patients (Brambilla et al, 
1975; Johnstone et al, 1977). Ferrier (1982) reported that 
there was no overall abnormality in testosterone secretion 
but that there was a mean reduction in both FSH and LH 
in male chronic schizophrenic patients compared with 
those suffering from manic-depressive illness and with 
aged-matched control subjects. These data suggest the 
possibility of decreased gonadal activity in schizophrenia. 
However, Tourney & Hatfield (1972) reported that the 
concentrations of serum testosterone were within the nor-
mal range in schizophrenia. Several investigators have 
reported high concentrations of gonadal hormones in the 
serum of schizophrenic patients (Brophy et al, 1983; 
Mason et al, 1988). The different findings may be related 
to neurochemical instability or heterogeneity in 
schizophrenia due to the regulation of the hypothalamic-
pituitary-gonadal activity by the neurotransmitters, espe-
cially dopami ne, i n the central nervous system (Hashi moto 
& Kimura, 1987; Davison & Kuenzel, 1991). 
In this study, we have simultaneously examined HVA, 
FSH, LH and testosterone in the serum of schizophrenic 
patients both on and off neuroleptic drugs, and healthy 
control subjects. The primary purpose was to explore the 
relationship between the activity of the pituitary-gonadal 
system and dopamine turnover, and between the levels of 
gonadal hormones in the circulation and the clinical state 
of the schizophrenic patients. 
METHODS 
Subjects: Twenty male schizophrenic patients who 
had not taken neuroleptic drugs for at least three months, 
aged 38.2 ± 13.0 years, 44 male schizophrenic patients 
who were taking neuroleptic drugs, aged 35.0 ± 10.3 
years, and 15 male healthy control subjects aged 
43.4± 11.7 years, came to the Schizophrenia Association 
of Great Britain, Bangor, North Wales, from all parts of 
the United Kingdom. These patients had been ill for 1.5 to 
41 years since the onset of the illness or first admission to 
hospital. Their diagnoses were made by the psychiatrists 
who treated them initially, and confirmed when they came 
for interview and blood collection. They were divided into 
two groups, fairly well and actively ill, according to their 
clinical state at the time oftheinterviews(Weietal, 1992). 
The fairly well patients included those who were in remis-
sion, or capable of full time work, or who were slightly 
psychotic; the actively ill patientsincluded those who were 
not capable of work, or with visibly psychotic symptoms. 
No patients who were severely ill were included in this 
study. The neuroleptic drugs that these patients were 
taking included chlorpromazine, clozapine, flupenthixol, 
fluphenazine, haloperidol, pimozide, sulpiride, 
thioridazine, trifluoperazine and zuclopenthixol, anVthe 
dose ranges were similar to those mentioned earlier (Wei 
et al, 1992). Some patients were taking more than one of 
these drugs. 
Blood sample collection and measurements: All the 
volunteers travelled the day before blood collection and 
they did not eat from 22.00 hours of that day until the blood 
samples were taken the next morning. They were asked 
about their health and medical histories, including mental 
and physical illnesses, infectious diseases, as well as any 
drugs they were taking. They all signed the consent forms 
and remained sitting for 15 to 20 minutes prior to blood 
collection. Venous blood was drawn from the ante-cubital 
vein between 8:00 and 9:00 a.m. and cooled to 2-4° C 
immediately. The serum was separated by centrifugation 
at a speed of 2000 rpm at 4° C for 15 minutes, and aliquots 
of 0.5 to 1.0 ml were stored in a deep freezer at -45° C, 
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until they were assayed within 10 weeks after the blood 
samples were taken. 
Serum HVA was measured by a high performance 
liquid chromatography (HPLC) with electrochemical 
detection, which has been described in a previous study 
(Wei et al, 1992). Serum testosterone, LH and FSH were 
determined by radioimmunoassay (I -RIA systems, 
Pharmacia Ltd, U.K.). 
All samples were measured in duplicate and blindly. 
The Kurskal-Wallis one-way analysis of variance, a two-
tailed t-test, and Pearson correlation were used for the 
analysis of the data. 
RESULTS 
Kruskal-Wallis analysis of variance showed no sig-
nificant differences among the three groups in serum HVA 
(H=3.54, df=2, p>0.1), FSH (H=4.75, df=2, p>0.05), LH 
(H=4.19, df=2, p>0.1) and testosterone (H=4.03, df=2, 
P>0.1). 
Table 1 
Concentrations of serum HVA, FSH, LH and T in schizophrenic 
patients and control subjects. 
Measurements 
HVA(g/L) 
FSH (IU/L) 
LH (IU/L) 
T (nmol/L) 
Drug-free 
Mean 
10.4 
5.2 
7.5 
35.8: 
±SD n 
± 5.5 18 
±2.1 19 
±3.3 18 
±14.320 
Drug-treated 
Mean 
8.4 
4.6 
6.0 
29.2: 
i±SD 
±3.4 
±3.6 
±3.6 
n 
44 
41 
40 
±10.9 43 
Control 
Mean 
8.6 
4.9 
5.2 
26.3: 
±SD 
±3.6 
±2.0 
±2.2 
t14.3 
n 
15 
15 
14 
14 
A trend towards a higher concentration of serum HVA, 
FSH, LH and testosterone was found in patients not taking 
neuroleptic drugs than in those treated with neuroleptic 
drugs or in normal control subjects, but this was not 
significant (Table 1). 
DISCUSSION 
The present results demonstrate that there appears to 
be an increased activity of the pituitary-gonadal system in 
patients not taking neuroleptic drugs. This may be related 
to dopaminergic activity, as serum HVA also increases 
(Table 1). Circulating HVA, as a major metabolite of 
dopamine, may partly reflect dopamine turnover in the 
brain, since about half of the HVA in circulation is thought 
to derive from this source (Sternberg et al, 1983), par-
ticularly under conditions of controlled diet and physical 
activity, which minimize exogenous or peripheral con-
tributions to circulating HVA (Kendler et al, 1983). 
There is evidence that dopamine stimulates the 
pituitary-gonadal system through a central pathway 
(Markaryan, 1983; Hashimoto & Kimura, 1987). Recent-
ly, Davison and Kuenzel (1991) reported that the increased 
dopamine in the median eminence showed an excitatory 
role in gonadotropin release at puberty. The present study 
indicates that the concentrations of serum FSH, LH and 
testosterone tended to be lower in the patients taking 
neuroleptic drugs than in those not taking them (Table 1). 
Similar findings have been described by other inves-
tigators (Brown et al, 1978; Riniers et al, 1988, 1989). 
These data support the possibility that the increase of 
pituitary-gonadal activity may result from the dopaminer-
gic overactivity in schizophrenia. 
However, dopaminergic overactivity is not sufficient 
to explai n the etiology and pathogenesis of schizophrenia, 
although the dopamine hypothesis has been the most 
popular over the past three decades (Seeman, 1987; 
Reynolds, 1989). This is because neuroleptic drugs are not 
very effective in some cases (Bowers et al, 1984; Chang 
et al, 1990), and because low concentrations of dopamine 
metabolites, such as HVA, have been found in in body 
fluids of some patients who were not treated with 
neuroleptic drugs (Van Kammen et al, 1986; Davidson & 
Davis, 1988). This is a possible reason for the difference 
in changes of pituitary-gonadal hormones in 
Schizophrenia. 
On the other hand, there was a state-dependent trait in 
the neurochemistry of schizophrenia (Van Kammen et al, 
1985). Davis et al (1985) reported that the concentrations 
of plasma HVA before treatment were highly correlated 
with the severity of the illness. However, we did not find 
a significant difference in the serum HVA between 
patients who were fairly well and those who were actively 
ill, in those who were either treated or not treated with 
neuroleptic drugs. 
There was a significant positive correlation between 
serum HVA and FSH only in patients not taking neurolep-
tic drugs (r=0.55, n=16, p <0.05). This finding suggests 
that both HVA and FSH in the circulation could be used 
as an index to assess dopaminergic activity in 
schizophrenia. It could, perhaps, be of importance in the 
diagnosis and treatment of schizophrenia. 
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